ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,972 | -11.7% | 17,720 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $40,756 | -1.3% | 17,720 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $41,288 | 0.0% | 17,720 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $41,288 | +21.4% | 17,720 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $34,000 | -29.2% | 17,720 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $48,000 | -9.4% | 17,731 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $53,000 | +8.2% | 17,720 | +39.3% | 0.00% | 0.0% |
| Q4 2021 | $49,000 | -10.9% | 12,720 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $55,000 | +52.8% | 12,720 | +8.5% | 0.00% | 0.0% |
| Q2 2021 | $36,000 | – | 11,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |